Correlation Between Walker Dunlop and Hemogenyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Hemogenyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Hemogenyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Hemogenyx Pharmaceuticals PLC, you can compare the effects of market volatilities on Walker Dunlop and Hemogenyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Hemogenyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Hemogenyx Pharmaceuticals.
Diversification Opportunities for Walker Dunlop and Hemogenyx Pharmaceuticals
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Walker and Hemogenyx is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Hemogenyx Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemogenyx Pharmaceuticals and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Hemogenyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemogenyx Pharmaceuticals has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Hemogenyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Walker Dunlop and Hemogenyx Pharmaceuticals
Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 50.32 times less return on investment than Hemogenyx Pharmaceuticals. But when comparing it to its historical volatility, Walker Dunlop is 20.97 times less risky than Hemogenyx Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Hemogenyx Pharmaceuticals PLC is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 95,000 in Hemogenyx Pharmaceuticals PLC on November 5, 2024 and sell it today you would lose (58,550) from holding Hemogenyx Pharmaceuticals PLC or give up 61.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 99.4% |
Values | Daily Returns |
Walker Dunlop vs. Hemogenyx Pharmaceuticals PLC
Performance |
Timeline |
Walker Dunlop |
Hemogenyx Pharmaceuticals |
Walker Dunlop and Hemogenyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Walker Dunlop and Hemogenyx Pharmaceuticals
The main advantage of trading using opposite Walker Dunlop and Hemogenyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Hemogenyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemogenyx Pharmaceuticals will offset losses from the drop in Hemogenyx Pharmaceuticals' long position.Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |